GWS
SRPT icon

Glassman Wealth Services’s Sarepta Therapeutics SRPT Stock Holding History

Glassman Wealth Services’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-107
Closed -$10.3K – 1586
2023
Q4 		$10.3K Buy
107
+10
+10% +$959 ﹤0.01% 874
2023
Q3 		$11.8K Sell
97
-1
-1% -$113 ﹤0.01% 809
2023
Q2 		$11.2K Hold
98
– – ﹤0.01% 781
2023
Q1 		$13.5K Sell
98
-1
-1% -$130 ﹤0.01% 728
2022
Q4 		$12.8K Buy
99
+1
+1% +$116 ﹤0.01% 766
2022
Q3 		$11K Hold
98
– – ﹤0.01% 775
2022
Q2 		$7K Sell
98
-59
-38% -$4.34K ﹤0.01% 924
2022
Q1 		$12K Sell
157
-35
-18% -$2.68K ﹤0.01% 786
2021
Q4 		$17K Buy
192
+21
+12% +$1.79K ﹤0.01% 662
2021
Q3 		$16K Buy
171
+80
+88% +$6.16K ﹤0.01% 646
2021
Q2 		$7K Buy
91
+84
+1,200% +$6.37K ﹤0.01% 845
2021
Q1 		$1K Sell
7
-88
-93% -$8.12K ﹤0.01% 1325
2020
Q4 		$16K Buy
95
+56
+144% +$8.3K ﹤0.01% 597
2020
Q3 		$5K Buy
39
+3
+8% +$456 ﹤0.01% 803
2020
Q2 		$6K Buy
36
+19
+112% +$2.59K ﹤0.01% 597
2020
Q1 		$2K Buy
17
+5
+42% +$572 ﹤0.01% 751
2019
Q4 		$2K Hold
12
– – ﹤0.01% 789
2019
Q3 		$1K Hold
12
– – ﹤0.01% 916
2019
Q2 		$2K Sell
12
-1
-8% -$122 ﹤0.01% 749
2019
Q1 		$2K Buy
+13
New +$1.67K ﹤0.01% 721
2018
Q4 		– Sell
-5
Closed -$1K – 971
2018
Q3 		$1K Hold
5
– – ﹤0.01% 739
2018
Q2 		$1K Hold
5
– – ﹤0.01% 725
2018
Q1 		$0 Hold
5
– – ﹤0.01% 912
2017
Q4 		$0 Buy
+5
New +$265 ﹤0.01% 782

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Glassman Wealth Services's SRPT Position: Q1 2024 in Review

Glassman Wealth Services sold out of Sarepta Therapeutics (SRPT) in Q1 2024, closing a stake of 107 shares — an estimated $10.3K sold.

Glassman Wealth Services first reported a position in SRPT in Q4 2017 and held it in 24 quarters. The position peaked at $17K in Q4 2021. 414 funds tracked by Wall St. Rank hold SRPT as of Q1 2024.

  • Glassman Wealth Services reported no remaining Sarepta Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 107 Sarepta Therapeutics shares in Q1 2024, an estimated $10.3K.
  • Glassman Wealth Services first reported a position in Sarepta Therapeutics in Q4 2017 and held it in 24 quarters.
  • Glassman Wealth Services's Sarepta Therapeutics position peaked at $17K in Q4 2021.
  • 414 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.